arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Processa Pharmaceuticals, Inc.

PCSA

$2.61 ▲ +0.30 (+13.23%) at close

15 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Processa Pharmaceuticals, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $3.4M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -198.1% ↗

FCF / Share $-8.70 ↘

Trailing P/E —

Price / Book 26.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-13.56M

↓ -14.5% —

FCF / Share Free cash flow per share

$-8.70

↓ -136.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	-95.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1295%)	-43.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-642%)	-35.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-549%)	62.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+683%)	—	—
EPS Growth YoY (%)	-167.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	54.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	75.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-14.5% Weak ↑ Weak Improving Year-over-year change in net income	-6.6% Weak ↑ Weak Improving Year-over-year change in net income	59.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-140.0% Weak ↓ Weak Declining Year-over-year change in net income	20.7% Good ↑ Good Improving Year-over-year change in net income	-329.3% Weak ↓ Weak Declining Year-over-year change in net income	10.8% Fair ↑ Fair Improving Year-over-year change in net income	-102.8% Weak ↑ Weak Improving Year-over-year change in net income	-452.5% Weak ↓ Weak Declining Year-over-year change in net income	90.0% Excellent ↑ Excellent Improving Year-over-year change in net income	25.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-47.5% Weak Weak Year-over-year change in net income	-25.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-136.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	40.2% Excellent Excellent Year-over-year change in free cash flow	48.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	-74.8% Weak Weak Compound annual revenue growth over 3 years	-16.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	4.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.2% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.3% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-198.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-561.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-181.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-291.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-61.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-381.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-179.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-373.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-198.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-319.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-60.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-60.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-243.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1721%)	—	-222.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1586%)	—	-44.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-399%)	-62.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-519%)	-41.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-379%)	-38.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-359%)	—	14.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	169.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1030%)	—	-183.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1324%)	-95.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-735%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Interest Coverage (x)	-2494.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10009.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-33518.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-53.84x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-107.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-28.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	-30.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-5.54M	$-1.19M	$-4.71M	$-6.50M	$-16.50M	$-15.42M	$-691.54K	$-1.74M	$-2.85M	$-3.24K	$-2.09K	$-21.23K	$-186.86K	$-1.02M	$-2.79M

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	$-10.36	$-3.87	$-8.48	$-34.05	—	—	—	—	$-0.06	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-8.70	$-3.68	$-6.15	$-11.92	—	—	—	—	$-0.05	—	—	—	—	—	—
Book Value per Share (USD)	$0.10	$0.46	$3.88	$9.32	$1.62	$1.62	$1.46	$1.76	$0.01	$-0.21	$-0.18	$0.11	$0.21	—	—
Tangible Book Value per Share (USD)	$0.10	$0.46	$3.88	$9.32	$1.11	$0.99	$-0.30	$-0.13	$0.01	$-0.21	$-0.18	$0.11	$0.21	—	—
Basic Weighted Avg Shares (shares)	1.31M	3.06M	1.31M	805,477	—	—	—	—	32.60M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$3.43M	$340.99K	$4.90M	$7.39M	$17.36M	$14.98M	$-184.42K	$1.37M	$351.77K	$-2.35M	$-1.98M	$-460.84K	$-607.01K	$441.39K	—
Total Equity (USD)	$5.58M	$1.70M	$4.99M	$7.47M	$25.49M	$22.94M	$8.01M	$9.70M	$373.16K	$-2.35M	$-1.98M	$1.21M	$1.67M	$2.56M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	$0.00	—	—	—	—	$5.00K	$113.42K	$200.20K	$312.48K	$192.15K	—
Depreciation Expense (USD)	$1.20K	$782.00	$222.00	—	$484.00	$8.45K	$8.45K	$8.45K	$1.86K	$159.00	$60.25K	$104.12K	$57.76K	$19.18K	—
Net Income, GAAP (USD)	$-13.56M	$-11.85M	$-11.12M	$-27.42M	$-11.43M	$-14.41M	$-3.36M	$-3.77M	$-1.86M	$-335.98K	$-3.35M	$-4.53M	$-3.07M	$-2.44M	—
Operating Cash Flow (USD)	$-11.39M	$-11.25M	$-8.06M	$-9.61M	$-8.72M	$-3.14M	$-2.75M	$-3.71M	$-1.65M	$-43.20K	$-871.91K	$-2.70M	$-2.54M	$-1.89M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 56 quarters

Processa Pharmaceuticals, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PCSA with peers